日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Does the Change of Weather Influence Disease Activity in Rheumatoid Arthritis Patients: Patients' Self-Assessment via WebApp

天气变化是否会影响类风湿性关节炎患者的疾病活动度：患者通过网络应用程序进行的自我评估

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm13175336
Poller, Martin; Schulz, Martin M P; Schulze-Koops, Hendrik; Kyburz, Diego; von Kempis, Johannes; Mueller, Ruediger B
关节炎
发表日期：2024
文献求助 收藏

Radiographic Progression in Patients with Rheumatoid Arthritis in Clinical Remission or Low Disease Activity: Results from a Swiss National Registry (SCQM)

类风湿性关节炎临床缓解期或低疾病活动度患者的放射学进展：来自瑞士国家注册研究（SCQM）的结果

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm13237424
Brandt, Lena L N; Schulze-Koops, Hendrik; Hügle, Thomas; Nissen, Michael J; Kempis, Johannes von; Müeller, Ruediger B
关节炎
发表日期：2024
文献求助 收藏

Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care

在接受常规临床治疗的类风湿性关节炎患者中，与生物制剂相比，托法替尼存在严重的感染风险。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-44841-w
Riek, Myriam; Scherer, Almut; Möller, Burkhard; Ciurea, Adrian; von Mühlenen, Ines; Gabay, Cem; Kyburz, Diego; Brulhart, Laure; von Kempis, Johannes; Mueller, Ruediger B; Hasler, Paul; Strahm, Tanja; von Känel, Sabine; Zufferey, Pascal; Dudler, Jean; Finckh, Axel
炎症/感染
关节炎
发表日期：2023
文献求助 收藏

Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)

剂量调整对托法替尼治疗类风湿性关节炎患者的疗效和安全性的影响：一项开放标签、长期扩展研究（ORAL Sequel）的事后分析

期刊:Clinical Rheumatology
影响因子:2.8
doi:10.1007/s10067-021-05908-z
Mueller, Ruediger B; Schulze-Koops, Hendrik; Furst, Daniel E; Cohen, Stanley B; Kwok, Kenneth; Wang, Lisy; Killeen, Tim; von Kempis, Johannes
关节炎
发表日期：2022
文献求助 收藏

Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors

肿瘤坏死因子抑制剂治疗中轴型脊柱关节炎患者附着点炎的部位特异性缓解

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-021-02534-7
Nissen, Michael J; Möller, Burkhard; Ciurea, Adrian; Mueller, Ruediger B; Zueger, Patrick; Schulz, Martin; Ganz, Fabiana; Scherer, Almut; Papagiannoulis, Eleftherios; Hügle, Thomas
关节炎
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data from the St. Gallen and Aarau Cohorts

托法替尼治疗类风湿性关节炎的有效性、耐受性和安全性：来自圣加仑和阿劳队列的真实世界数据的回顾性分析

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm8101548
Mueller, Ruediger B; Hasler, Caroline; Popp, Florian; Mattow, Frederik; Durmisi, Mirsada; Souza, Alexander; Hasler, Paul; Rubbert-Roth, Andrea; Schulze-Koops, Hendrik; Kempis, Johannes von
关节炎
发表日期：2019
文献求助 收藏

Superiority of a Treat-to-Target Strategy over Conventional Treatment with Fixed csDMARD and Corticosteroids: A Multi-Center Randomized Controlled Trial in RA Patients with an Inadequate Response to Conventional Synthetic DMARDs, and New Therapy with Certolizumab Pegol

与固定剂量传统合成DMARD和糖皮质激素的常规治疗相比，达标治疗策略更优：一项针对对常规合成DMARD和新型Certolizumab Pegol疗法反应不足的类风湿关节炎患者的多中心随机对照试验

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm8030302
Mueller, Ruediger B; Spaeth, Michael; von Restorff, Cord; Ackermann, Christoph; Schulze-Koops, Hendrik; von Kempis, Johannes
关节炎
免疫/内分泌
发表日期：2019
文献求助 收藏

Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: results from the Swiss prospective observational cohort

早期未分化关节炎的临床和影像学病程与诊断时关节侵蚀的数量无关：来自瑞士前瞻性观察队列研究的结果

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2018-000673
Mueller, Ruediger B; Kaegi, Toni; Haile, Sarah R; Schulze-Koops, Hendrik; Schiff, Michael; von Kempis, Johannes
关节炎
发表日期：2018
文献求助 收藏

Improvement of primary biliary cholangitis (PBC) under treatment with sulfasalazine and abatacept

柳氮磺胺吡啶和阿巴西普治疗可改善原发性胆汁性胆管炎（PBC）。

期刊:BMJ Case Reports
影响因子:0.5
doi:10.1136/bcr-2018-224205
Popp, Florian; Semela, David; von Kempis, Johannes; Mueller, Ruediger B
发表日期：2018
文献求助 收藏

Treatment with Biologicals in Rheumatoid Arthritis: An Overview

生物制剂在类风湿性关节炎治疗中的应用：概述

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-017-0073-3
Rein, Philipp; Mueller, Ruediger B
关节炎
发表日期：2017
文献求助 收藏